Question · asked by 1 review
Insulin vs anti‐diabetic agent: Perinatal (fetal and neonatal death) and later infant mortality
- Population
- Infants of women diagnosed with gestational diabetes
- Intervention
- Insulin
- Comparison
- anti‐diabetic agent
- Outcome
- Perinatal (fetal and neonatal death) and later infant mortality
Insulin showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with anti‐diabetic agent (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Insulin vs anti‐diabetic agent Perinatal (fetal and neonatal death) and later infant mortality · Infants of women with gestational diabetes. Insulin showed no clear difference in perinatal (fetal and neonatal death) and later infant mortality compared with anti‐diabetic agent (low certainty). Insulin for the treatment of women with gestational diabetes (2017) · Cochrane Headline outcomes only | RR 0.85 [0.29, 2.49] | 10 studies · 1463 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Insulin for the treatment of women with gestational diabetes 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.